Cardiovascular Medicine 2021
Updates for the Practitioner
Fairmont Copley Plaza • May 2 - 6, 2021
This is the schedule from 2019. 2021 schedule not yet available.
Sunday · April 28, 2019
6:30am to 7:45am Registration and Breakfast
7:45am to 8:00am Seating
8:00am to 8:15am Welcome, Introductions, Course Objectives
Samuel Z. Goldhaber, MD, Peter Libby, MD, and Patrick T. O'Gara, MD
Atherosclerosis, Inflammation, Thrombosis, and Risk Factors
Co-Chairs: Samuel Z. Goldhaber, MD and Patrick T. O'Gara, MD
8:15am to 8:45am Inflammation: At the Nexus of Atherosclerosis, Aging, and Cancer
Peter Libby, MD
8:45am to 8:55am Discussion, Q&A
8:55am to 9:25am CANTOS: Effect of Interleukin-1β Inhibition with Canakinumab on Atherosclerosis and Lung Cancer
Paul M Ridker, MD, MPH
9:35am to 10:05am Reducing Triglyceride Levels to Reduce Adverse Cardiovascular Outcomes
Aruna D. Pradhan, MD, MPH
10:05am to 10:15am Discussion, Q&A
10:15am to 10:35am Coffee break
Refreshments provided
10:35am to 11:05am Statins, Ezetimibe, and PCSK9 Inhibitors to Lower LDL Cholesterol: How Low Can You Go?
Jorge Plutzky, MD
Thomas W. Smith, MD Memorial Lecture
Session Chair: Peter Libby, MD
11:15am to 12:00pm Heart Failure with Preserved Ejection Fraction
Nancy K. Sweitzer, MD, PhD
12:00pm to 12:10pm Discussion, Q&A
12:10pm to 1:10pm Break for lunch*
Advanced Heart Failure
Session Chairs: Akshay S Desai, MD, MPH and Anju Nohria, MD
1:10pm to 1:40pm Ventricular Assist Devices and the Artificial Heart
Mandeep Mehra, MD
1:40pm to 1:50pm Discussion, Q&A
1:50pm to 2:20pm Cardiac Transplantation: Current and Future Perspectives
Michael M. Givertz, MD
2:30pm to 3:00pm Heart Failure with Reduced Ejection Fraction
Akshay S. Desai, MD, MPH
3:10pm to 3:40pm Health-Related Quality of Life Outcomes in Heart Failure
Eldrin F. Lewis, MD, MPH
3:50pm to 4:10pm Snack break
4:10pm to 4:40pm Cardiac Amyloidosis: New Treatments, New Hope
Rodney H. Falk, MD
4:50pm to 5:20pm The Burgeoning Field of Cardio-Oncology
Anju Nohria, MD
5:30pm to 6:00pm Heart Failure in Adult Congenital Heart Disease: An Echocardiographic Montage
Keri Shafer, MD
Monday · April 29, 2019
6:30am to 7:45am Breakfast
Session Chairs: Usha Tedrow, MD and Paul Zei, MD, PhD
8:00am to 8:30am Epidemiology of Atrial Fibrillation: New Emphasis on Modification of Cardiovascular Risk Factors and New Concept of Atrial Fibrillation as a Systemic Cardiovascular Illness
Usha Tedrow, MD
8:40am to 9:10am Atrial Fibrillation: Pharmacological Therapy and New Approaches to Ablation in the EP Lab
Paul Zei, MD, PhD
9:20am to 9:50am Management of Atrial Fibrillation by the General Cardiologist: Lessons from Randomized and Observational Clinical Trials
David T. Martin, MD
9:50am to 10:00am Discussion, Q&A
10:20am to 10:50am Is There a Role for Electronic Decision Support in the Management of Atrial Fibrillation and Other Cardiovascular Illnesses?
Samuel Z. Goldhaber, MD
11:00am to 11:30am Atrial Fibrillation in Hypertrophic Cardiomyopathy: Pathogenesis and Management
Neal K. Lakdawala, MD, MSc
Master Mentor Featured Lecture
11:40am to 12:25pm Atrial Fibrillation and Coronary Artery Disease: A Perilous Combination
Deepak L. Bhatt, MD, MPH
Valvular Heart Disease: Diagnostic, Cath Lab, and Surgical Approaches
1:35pm to 2:05pm Tricuspid Valve Disease
Dale S. Adler, MD
2:15pm to 2:45pm Mitral Valve Disease
Patrick T. O'Gara, MD
2:55pm to 3:25pm Aortic Valve Disease
Yee-Ping Sun, MD
3:55pm to 4:25pm Transcatheter Aortic Valve, Mitral Valve, and Tricuspid Valve Therapies
Pinak B. Shah, MD
4:35pm to 5:05pm Idiopathic Pulmonary Hypertension: Definition, Diagnosis, and Epidemiology
Bradley A. Maron, MD
5:15pm to 5:45pm Idiopathic Pulmonary Hypertension: Combination Pharmacological Therapy—Rationale and Results
Aaron B. Waxman, MD, PhD
5:55pm to 6:25pm Chronic Thromboembolic Pulmonary Hypertension
William Auger, MD
Tuesday · April 30, 2019
Coronary Artery Disease: Challenges and Conceptual Changes
Session Chair: Michelle L. O'Donoghue, MD, MPH
8:00am to 8:30am Management of Acute Coronary Syndromes
Marc S. Sabatine, MD, MPH
8:40am to 9:10am New Approaches to STEMI in the Cardiac Cath Lab: Should Our Goal Be Complete Revascularization? What Are Our Options for Intravenous Antiplatelet Therapy?
Brian A. Bergmark, MD
9:20am to 9:50am Long-Term Antiplatelet Therapy for Coronary Artery Disease: Single, Dual, or Even Triple Therapy? How Intense? Optimal Duration? Should Aspirin Be the First Antiplatelet Agent That We Discontinue?
Michelle L. O'Donoghue, MD, MPH
10:20am to 10:50am Total Coronary Occlusion: The Last Fronier and Greatest Challenge for the Interventionalist in the Cath Lab
Kevin J. Croce, MD, PhD
11:00am to 11:30am The Aspirin Perplex: Whom to Treat and What Dose to Use?
Samia Mora, MD
Kenneth L. Baughman, MD Memorial Lecture
Session Chair: Patrick T. O'Gara, MD
11:40am to 12:25pm Sudden Cardiac Death: Identifying Patients at High Risk, Optimizing Preventive Measures, and Managing Patients Who Are Successfully Resuscitated
Gordon F. Tomaselli, MD
Session Chair: Samuel Z. Goldhaber, MD
1:35pm to 2:05pm DOACs: The Good, the Bad, and the Ugly
2:15pm to 2:45pm Management of Major Bleeding Complications in Anticoagulation Patients
Jean M. Connors, MD
2:55pm to 3:10pm Transition to Breakout Sessions
Breakout Sessions I, II, III
Program participants will have the opportunity to attend all three breakout sessions.
3:10pm to 4:00pm Breakout Sessions I, II, III
Session I: Difficult Dilemmas That My Patients and I Have Confronted
Session II: Thrombophilia, Bleeding, and Clotting Cases
Umberto Campia, MD, MS
Session III: Vascular Medicine in the Office and Interventional Lab: Cases I'll Never Forget
Brian Bergmark, MD
4:00pm to 4:10pm Transition
Wednesday · May 1, 2019
7:30am to 7:50am Lymphedema and Limb Swelling: Assessment and Cutting Management
Brett Carroll, MD
8:00am to 8:30am Cold and Blue Fingers and Toes: Work-Up and Management
Marie D. Gerhard-Herman, MD
8:40am to 9:10am Pulmonary Embolism Response Teams: Optics and Options—Rolling Out a Coordinated Communications Strategy
9:20am to 9:50am Pulmonary Embolism and DVT: Epidemiology, Pathophysiology, Misconceptions, and Management Overview
10:20am to 10:50am Peripheral Arterial Disease: Lessons from the COMPASS Trial and Implementation of Combination Anticoagulation and Antiplatelet Therapy
11:00am to 11:30am Quiz: Vascular Diagnostic Lab Cases
Piotr Sobieszczyk, MD
Featured Presentation: Joseph Loscalzo, MD, PhD
11:40am to 12:25pm Case Discussion: From Bedside to Bench
Joseph Loscalzo, MD, PhD
Session Chairs: Bruce Koplan, MD and Usha Tedrow, MD
1:35pm to 2:05pm Ventricular Tachycardia "Storm" and Other EP Emergencies: A Case-Based Approach to Management, including Ventricular Tachycardia Ablation
2:15pm to 2:45pm Rapid-Fire Case-Based Arrhythmia Quiz
Bruce Koplan, MD
Multimodality Cardiovascular Imaging and Stress Testing
Session Chairs: Justina C. Wu, MD, PhD and Marcelo F. DiCarli, MD
2:55pm to 3:25pm How to Select, Use, and Integrate the Results of Cardiovascular Imaging Tests: CT, Magnetic Resonance, and Nuclear Imaging
Ron Blankstein, MD
3:35pm to 3:55pm Coffee break
3:55pm to 4:25pm Challenges and Advances in Transthoracic and Transesophageal Echocardiography
Justina C. Wu, MD, PhD
4:35pm to 5:05pm How to Choose the Best Stress Test: Exercise Treadmill, Exercise Bicycle, Exercise ECHO, Nuclear, or Magnetic Resonance
Marcelo F. DiCarli, MD
5:15pm to 5:45pm Cardiac Magnetic Resonance Imaging: Sarcoid, Amyloid, Pericardial Inflammation, Hemochromatosis, and Other Cardiac Infiltrative Diseases
Raymond Y. Kwong, MD, MPH
5:55pm to 6:25pm Cardiopulmonary Exercise Testing: Indications, Noninvasive, and Invasive
Thursday · May 2, 2019
8:00am to 8:30am The Emerging Field of Critical Care Cardiology: Managing Multisystem Organ Failure in Patients with Underlying Catastrophic Cardiac Insult
Erin Bohula, MD, DPhil
Genetics: Relevance to Daily Clinical Practice
Session Chair: Carolyn Y. Ho, MD
8:40am to 9:10am Primer on Essential Genetics for the Practicing Clinician: A Case-Based Approach
Rajat M. Gupta, MD
9:20am to 9:50am Implications of a Genetics Workup in Hypertrophic Cardiomyopathy: How Genetic Profiling Can Inform the Decision to Implant or Withhold an Internal Cardiac Defibrillator
Carolyn Y. Ho, MD
10:20am to 10:50am Arrhythmogenic Cardiomyopathy: When and Why Refer to a Cardiovascular Geneticist?
11:00am to 11:30am Randomized and Observational Trials of Heart Failure: Lessons I Have Learned as a Clinician
Scott D. Solomon, MD
Featured Presentation: Eugene Braunwald, MD
11:40am to 12:25pm Heart Disease: Past, Present, and Future
Eugene Braunwald, MD
Diabetes and Cardiovascular Disease: Engaging the Clinical Cardiologist
Session Chairs: Benjamin M. Scirica, MD and Jorge Plutzky, MD
1:35pm to 2:05pm Exponential Advances in Our Understanding of Pharmacological Therapy to Reduce Heart Attack, Stroke, and Cardiovascular Death in Patients with Diabetes: Gleaning Information from a Series of Remarkable Randomized Control Trials
Marc A. Pfeffer, MD, PhD
2:15pm to 2:45pm A New Day Dawns in Management of CV Risk in Diabetes Mellitus: Attacking from All the Angles
Benjamin M. Scirica, MD
2:55pm to 3:25pm Playing Against a Stacked Deck: Managing Cardiovascular Risk in Chronic Kidney Disease
Ajay Singh, MD
3:35pm to 4:05pm Diabetes Mellitus for the Clinical Cardiologist: A Step-Wise Approach to Management—Do We Have to Start with Metformin? Should We Prescribe Routinely the Newest Agents That Reduce Cardiovascular Outcomes with Only Modest Reduction of Hemoglobin A1C?
Enrico Cagliero, MD
Cardiovascular Management of Complicated Pregnancy
4:15pm to 4:45pm Cardiovascular Management of Complicated Pregnancy
Anne Marie Valente, MD
4:55pm to 5:00pm Concluding Remarks and Wrap-Up
5:00pm Course Adjourns
*There are many convenient and varied lunch options within a short walking distance of the course.
Upon completion of this course, participants will be able to:
Utilize new strategies to lower LDL cholesterol with high potency statins, ezetimibe, and PCSK9 inhibitors
Implement options to manage advanced heart failure: pharmacological, mechanical circulatory support, and heart transplantation
Undertake a comprehensive management approach to atrial fibrillation
Integrate multimodality cardiovascular imaging: magnetic resonance, coronary CT, nuclear medicine, and echocardiography
Recognize the latest advances in atrial fibrillation and ventricular tachycardia ablation in the EP lab
Treat diabetes mellitus to reduce heart attack, stroke, and cardiovascular death
Differentiate the latest nuances of five FDA-approved direct oral anticoagulants and distinguish among various strategies to reverse major bleeding
Respond with a wide range of options as a member of a Pulmonary Embolism Response Team
Overview contemporary cath lab interventions for STEMI and chronic totally occluded coronary arteries
Synthesize indications, techniques, and outcomes of transcatheter aortic valve replacement and transcatheter mitral valve therapies
Integrate clinical genetics into decision-making for a broad range of challenging patients
Investigate suspected pulmonary hypertension, determine its etiology, and embark upon appropriate combination pharmacological therapy
Assess and manage with confidence cold and blue fingers and toes
Program Note
Please note that program changes / substitutions may be made without notice.
This site was built by The Penzias Group